Alterity Therapeutics Limited (ASX:ATH)

Alterity Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 18, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	87	91	21	17	31	58
Market Cap Growth	-9.26%	335.04%	22.84%	-45.41%	-46.38%	230.89%
Enterprise Value	47	87	9	-8	-6	23
Last Close Price	0.01	0.01	0.00	0.01	0.01	0.03
PS Ratio	16.00	16.78	5.22	4.36	6.11	13.45
PB Ratio	2.05	2.15	1.52	0.75	0.88	1.92
P/TBV Ratio	2.05	2.15	1.52	0.75	0.88	1.92
EV/Sales Ratio	8.55	15.97	2.22	-	-	5.37
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.00	0.00
Net Debt / Equity Ratio	-0.95	-0.95	-0.90	-0.68	-0.98	-0.92
Net Debt / EBITDA Ratio	2.77	2.77	0.64	1.07	2.24	1.85
Net Debt / FCF Ratio	3.54	3.54	0.99	0.78	2.79	1.62
Asset Turnover	0.17	0.17	0.17	0.11	0.14	0.20
Quick Ratio	12.62	12.62	3.10	5.58	6.79	10.56
Current Ratio	12.98	12.98	3.54	6.17	7.07	10.92
Return on Equity (ROE)	-43.23%	-43.23%	-104.47%	-47.38%	-38.97%	-81.39%
Return on Assets (ROA)	-28.09%	-28.09%	-52.66%	-26.64%	-25.85%	-43.62%
Return on Capital Employed (ROCE)	-34.50%	-34.50%	-141.60%	-63.80%	-43.60%	-49.70%
Earnings Yield	-13.96%	-13.31%	-91.15%	-80.84%	-41.06%	-26.24%
FCF Yield	-	-12.55%	-60.11%	-117.35%	-39.72%	-29.72%
Buyback Yield / Dilution	-75.31%	-75.31%	-50.29%	-0.91%	-41.79%	-89.62%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.